Mode
Text Size
Log in / Sign up
N/A N=37 Randomized Treatment

An Evaluation of Integration Success and Maintenance of Short Implants in Maxillas Needing Sinus Augmentation

Tooth Disease · Partial Edentulism

Enrolled (actual)
37
Serious AEs
0.0%
Results posted
Oct 2013
Primary outcome: Primary: Integration Success of Implant — 17; 20 participants

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Dental Implant (Nanotite) (Device)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
ZimVie
Primary completion
Jul 2013

Outcome Measures

OutcomeResultp-value
PRIMARY
Integration Success of Implant
17; 20

Summary

This prospective randomized study will evaluate the integration success while supporting a prosthesis for short implants placed into maxillary sites having minimal bone height that would otherwise need sinus augmentation. The resources utilized during treatment will be assessed. Study (null) hypothesis: the overall benefit of using short length implants to avoid sinus augmentation procedures will offset differences in the cumulative implant survival rates observed between treatment groups.

Eligibility Criteria

Inclusion Criteria

  • patients of either sex and any race greater than 18 years of age
  • patients with partial edentulism in the posterior maxilla requiring a unilateral implant-supported maxillary prosthesis
  • patients with a residual alveolar floor of the sinus between 4 and 6 mm in height, as assessed on intraoral radiographs, and able to receive at least a 4mm wide implant
  • patients must be physically able to tolerate conventional surgical and restorative procedures

Exclusion Criteria

  • patients with active infection or severe inflammation in the areas intended for implant placement
  • patients with a > 10 cigarettes per day smoking habit
  • patients with uncontrolled diabetes or metabolic bone disease
  • patient with a history of therapeutic radiation to the head
  • patients who are known to be pregnant
  • patients with para-functional habits with evidence of severe bruxing or clenching
  • patients not able to commit to a 3 year follow-up program
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00725049). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search